While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...

True Corporation Plc's Research and Innovation Centre has partnered with OYMotion, a global leader in neurotechnology, to ...

Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development ...

Setting New Standards for Thai Healthcare by Enabling BCI Technology Through True’s Network and Digital Ecosystem to ...

VisionSys AI Inc. (NASDAQ: VSA) (“VSA” or the “Company”) today announced that it is in advanced discussions with a strategic investor regarding a proposed strategic investment. Based on the terms ...

Motif Neurotech announced today that it received FDA investigational device exemption (IDE) to evaluate its brain stimulation ...

Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational ...

Motif’s study primarily aims to validate the safety of its XCS system over a 12-month period following implantation.

Chery officially kicked off its 2026 International Business Summit today, themed "New Era, New Heights". Spanning five days, the event focuses on technology, integration, and ecosystem. A core ...

At the Gallaudet booth, attendees learned about how Gallaudet’s unique mission positions it as a global leader at the ...

Classys Inc. (KOSDAQ: 214150), a global medical aesthetics platform company, has released its latest Annual Report, outlining its cumulative installed base and business structure across international ...

Hourglass International, a specialty PPE solutions provider with over 20 years of industry expertise, today announced the launch of the Nusa200tm - a powder-free, latex-free nitrile exam glove proudly ...